A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This will be a single-center, randomized, parallel group, multiple dose administration,
double-blind, placebo-controlled study to evaluate the effects of YKP10811 on gastric, small
bowel, and colonic transit in patients with Chronic Constipation or Functional Constipation.
Four groups including a placebo group will be enrolled and will receive multiple oral doses
of YKP10811 or matching placebo.